Harry is a driven entrepreneur who completed his PhD in Supramolecular Chemistry at the University of Bristol. He has an in-depth knowledge of this technology and the field of chemical carbohydrate sensing in general. He is also the director and co-founder of two sister companies that have enabled the growth of Carbometrics.
Keith is a former senior executive of Lloyds Banking Group with many years of corporate finance experience. He acts as director and/or mentor to several companies ranging from a recent start-up in the hospitality sector to an AIM-listed software company with a market cap of >£500 million.
Anthony is Professor of Supramolecular Chemistry at the University of Bristol, and a world leader in the field of molecularly engineered sugar receptors. He has published nearly 200 articles in the top academic journals and has received several high profile academic awards.
Tom has a degree in Mathematics and Finance, a Masters in Actuarial Science and is a part qualified as an Actuary. He is driven and has a strong interest and knowledge of economics and start-ups, acting as finance director for Cabrometrics. Tom fills a number of roles including helping develop the business strategy, legal and IP, budgeting and forecasting, accounting, risk management and business administration.
Andy has worked in some leading academic institutions in the UK and Spain where his varied research activities have led to several high-impact articles and books. He has specific experience in funding acquisition and a previous chemical SME in which he led customer-driven research and development.
With over 30 years of experience in Business Development and Licensing, primarily in pharmaceutical and biotech companies and 15 years running her own consulting business, Plexsus Consulting, Jackie provides broad experience, strategic insight and knowledge of the global pharmaceutical industry. Jackie joined the Board in March 2020 following her involvement in the sale of Ziylo to Novo Nordisk, which led to the spin-out of Carbometrics.
As a consultant, Jackie has worked with both start-up companies and larger biotechs in multiple therapy areas to negotiate deals; she has served as Commercial Director for several biotechs on an interim basis. Prior to founding Plexsus, Jackie served as Commercial Director for GeneMedix plc, from 2000-2005, focused on biosimilar protein drugs. She has also worked for PA Consulting Group, Novo Nordisk, Boehringer Ingelheim and Warner Lambert. Jackie is on the Board of Imophoron Ltd, a UK based vaccine company and served on the Board of CanImGuide A/S, a Swedish immune-oncology company, from December 2018 to June 2020.
Andy is a Chemist by training, with degree and PhD from Imperial College. Driven to leverage cutting edge biotechnology, with a focus on exploiting membrane-proteins for single-molecule biosensing, he is addressing unmet needs in fields such as healthcare, environment and science. Andy was instrumental in the development of nanopore sequencing, having worked on the technology first at Oxford University with Prof. Hagan Bayley. Following this, he spent 9 years at Oxford Nanopore Technologies, most recently as the Senior Director of Advanced Research, and is an author and inventor on many publications and patents in the field.
Mike has over 25 years experience in synthetic organic chemistry and has held a number of senior positions in several companies. He has invaluable experience of process development and medicinal chemistry.
Miriam is an experienced supramolecular and synthetic organic chemist. She has worked for world-leaders in her field. She was a former University of Bristol/Novo Nordisk STAR Fellow in Prof. Davis’ group and Senior Scientist at Ziylo and then Carbometrics. Miriam led the R&D efforts in developing fluorescent glucose sensing assays using GBMs. Miriam now works as an independent consultant to Carbometrics.
Originally a Primary School Teacher, Charlie is passionate about Outreach and alongside her role as COO of Unit DX Science incubator she has coordinated and outreach program at Unit DX to engage primary school children with science; to-date over 1000 children have visited DX and Carbometrics have played a key part in helping develop activities with a focus on diabetes education.
Michael is a multifaceted chemist, having laboratory experience in the world-leading chemistry departments of Oxford, Manchester and Bristol, as well as the Institute of Cancer Research in Sutton. His PhD in molecular communication has provided him with extensive skills in supramolecular and peptide chemistry.
Rob is a passionate scientist who completed his PhD under Prof Anthony Davis at the University of Bristol, where he discovered the new GBM platform. As a result, he has a comprehensive understanding of the technology central to Carbometrics, as well as a vast array of skills in synthetic, analytical and supramolecular chemistry
Dan is a highly skilled synthetic organic chemist with PhD and postdoctoral experience from world-leading laboratories at the Universities of Manchester and Bristol. His expertise in highly polar chemistry, process development and IP protection make him perfectly suited to the role of Lead Process Chemist at Carbometrics
Guillem completed his PhD in supramolecular chemistry under the supervision of Prof. Pau Ballester at the Institute of Chemical Research of Catalonia (ICIQ), one of the world’s leading chemistry research institutes. During his thesis, he developed extensive skills in synthetic organic chemistry, as well as the skills to understand complex supramolecular systems operating in aqueous media.
Stacy obtained her masters degree in Chemistry from UCL. She works as a member of the research team alonglside managing the daily running of the lab. Stacy also coordinates the outreach programme for Carbometrics, reaching and engaging young people in science through school visits and online resources.
Mel is an experienced finance manager with specific experience running the finance departments of SMEs.